Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001104659-25-092569
Filing Date
2025-09-23
Accepted
2025-09-23 17:14:23
Documents
7
Period of Report
2025-11-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A pmn-20251117xpre14a.htm PRE 14A 286661
2 GRAPHIC pmn-20251117xpre14a_a003.jpg GRAPHIC 15980
3 GRAPHIC pmn-20251117xpre14a_bg001.jpg GRAPHIC 183190
4 GRAPHIC pmn-20251117xpre14a_bg002.jpg GRAPHIC 146710
5 GRAPHIC pmn-20251117xpre14a_bg003.jpg GRAPHIC 24689
6 GRAPHIC pmn-20251117xpre14a_cg001.jpg GRAPHIC 120195
7 GRAPHIC pmn-20251117xpre14a_cg002.jpg GRAPHIC 142364
  Complete submission text file 0001104659-25-092569.txt   1146523
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41429 | Film No.: 251334545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)